Mexico - Delayed Quote MXN
Vertex Pharmaceuticals Incorporated (VRTX.MX)
9,360.00
0.00
(0.00%)
As of April 21 at 12:57:20 PM CST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 23 | 22 | 30 | 27 |
| Avg. Estimate | 2.86B | 2.92B | 11.98B | 13.12B |
| Low Estimate | 2.7B | 2.77B | 11.75B | 11.85B |
| High Estimate | 2.97B | 3.01B | 12.45B | 14.43B |
| Year Ago Sales | 2.69B | 2.65B | 11.02B | 11.98B |
| Sales Growth (year/est) | 6.13% | 10.52% | 8.69% | 9.57% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VRTX.MX | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/1/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/31/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/20/2025 |
| Upgrade | Canaccord Genuity: Sell to Hold | 2/12/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/11/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/11/2025 |
Related Tickers
0RV2.IL BioArctic AB (publ)
185.40
+5.34%
0WA2.IL Cellectis S.A.
1.3040
-0.61%
ATQP.F Vericel Corporation
35.40
0.00%
RGO.SG Regeneron Pharmaceuticals Inc
523.60
+2.55%
ATHXQ Athersys, Inc.
0.0000
0.00%
ALCLS.PA Cellectis S.A.
1.3480
+2.74%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
+4.83%
TIL Instil Bio, Inc.
23.69
+43.66%
ADCT ADC Therapeutics SA
1.3150
+6.91%
RCUS Arcus Biosciences, Inc.
8.39
+3.64%